Clover Health Investments, Corp.
CLOV
$3.47
-$0.17-4.67%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 65.16% | 84.30% | 79.84% | 59.76% | 52.63% |
| Total Depreciation and Amortization | -17.88% | -41.95% | -46.95% | 94.27% | 105.58% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 8,059.43% | 759.14% | 55.66% | -112.93% | -99.20% |
| Change in Net Operating Assets | 12.71% | -10.64% | -49.17% | 66.12% | -188.46% |
| Cash from Operations | 77.33% | 96.27% | 124.09% | 22.96% | -255.90% |
| Capital Expenditure | -78.81% | -66.58% | -166.44% | 79.32% | 82.68% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -58.63% | -98.85% | -98.49% | -3.66% | 17.08% |
| Cash from Investing | -60.09% | -99.78% | -99.60% | 24.14% | 68.66% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 3,167.27% | 269.87% | -21.57% | -80.43% | -96.61% |
| Repurchase of Common Stock | -454.48% | -610.32% | -193.62% | -126.13% | -152.84% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -438.51% | -626.66% | -242.43% | -115.40% | -111.63% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 52.10% | 18.79% | 285.71% | -104.94% | -301.99% |